Your browser doesn't support javascript.
loading
Depression Moderates Physical Functioning Over Time in Survivors of Cancer.
Bamonti, Patricia M; Weiskittle, Rachel E; Naik, Aanand D; Bean, Jonathan F; Moye, Jennifer A.
Affiliation
  • Bamonti PM; Staff Psychologist, New England Geriatric Research Education and Clinical Center (GRECC), VA Boston Healthcare System, Brockton, MA; Instructor, Harvard Medical School, Boston, MA.
  • Weiskittle RE; Advanced Research Fellow, New England Geriatric Research Education and Clinical Center (GRECC), VA Boston Healthcare System, Brockton, MA; Advanced Research Fellow, Harvard Medical School, Boston, MA.
  • Naik AD; Investigator, Houston Center for Innovations in Quality, Effectiveness, and Safety; Michael E. DeBakey VA Medical Center, Houston, TX; Professor, Department of Medicine, Baylor College of Medicine, Houston, TX.
  • Bean JF; Director, New England Geriatric Research Education and Clinical Center (GRECC), VA Boston Healthcare System, Brockton, MA; Professor, Harvard Medical School, Boston, MA; Staff, Spaulding Rehabilitation Hospital, Boston, MA.
  • Moye JA; Associate Director for Education and Evaluation, New England Geriatric Research Education and Clinical Center (GRECC), VA Boston Healthcare System, Brockton, MA; Professor, Harvard Medical School, Boston, MA.
Rehabil Oncol ; 39(4): E98-E105, 2021 Oct.
Article in En | MEDLINE | ID: mdl-35663350
ABSTRACT

Background:

Cancer survivors are at risk for declines in physical functioning (PF). The strongest predictor of PF is prior PF. Clinically significant depression predicts declines in PF; however, the extent to which depression symptoms moderate the association between self-reported and performance-based measures of PF over time is unknown. Objective/

Purpose:

To examine whether level of depression symptoms in cancer survivors moderates the association of repeated self- and performance-based measures of PF at 6 and 18 months after cancer diagnosis.

Methods:

Prospective, observational study with assessment at 6 (T1), 12 (T2), and 18 months after cancer diagnosis (T3). Setting and Patients Community-dwelling US veterans with newly diagnosed head and neck, esophageal, gastric, or colorectal cancers. Measurements Measures included demographics, cancer variables (type, stage, severity, and treatment), depression symptoms (Patient Health Questionnaire-9 [PHQ-9]), Short Physical Performance Battery (SPPB), and self-reported PF (Patient-Reported Outcomes Measurement Information System-29 [PROMIS-29]).

Results:

Using hierarchical regression models, after adjustment for covariates, depression symptoms at T2 moderated the relationship between performance-based PF, SPPB (ß = -0.24, P = .001) but not self-reported PF, PROMIS (ß = -0.14, P = .05). In moderation analyses, SPPB T1 was only related to SPPB T3 when the PHQ-9 score was less than 9.

Limitations:

Majority White, male participants, did not measure chronicity of depression.

Conclusions:

Depression symptoms moderate the relationship of performance-based PF from baseline to 18 months.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Observational_studies / Prognostic_studies Aspects: Patient_preference Language: En Journal: Rehabil Oncol Year: 2021 Document type: Article Affiliation country: Morocco

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Observational_studies / Prognostic_studies Aspects: Patient_preference Language: En Journal: Rehabil Oncol Year: 2021 Document type: Article Affiliation country: Morocco